Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension

Patients undergoing total knee arthroplasty (TKA) report low satisfaction with postoperative pain control. The purpose of this study is to examine if there is a difference in post-operative pain for TKA patients without femoral nerve block receiving an intra-operative pericapsular injection of bupiv...

Full description

Bibliographic Details
Main Authors: Mark A. Snyder, MD, Christina M. Scheuerman, BSN, RN, Justin L. Gregg, MA, Christopher J. Ruhnke, MD, Kathryn Eten, BSN, RN
Format: Article
Language:English
Published: Elsevier 2016-03-01
Series:Arthroplasty Today
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344115000345
_version_ 1818839996968206336
author Mark A. Snyder, MD
Christina M. Scheuerman, BSN, RN
Justin L. Gregg, MA
Christopher J. Ruhnke, MD
Kathryn Eten, BSN, RN
author_facet Mark A. Snyder, MD
Christina M. Scheuerman, BSN, RN
Justin L. Gregg, MA
Christopher J. Ruhnke, MD
Kathryn Eten, BSN, RN
author_sort Mark A. Snyder, MD
collection DOAJ
description Patients undergoing total knee arthroplasty (TKA) report low satisfaction with postoperative pain control. The purpose of this study is to examine if there is a difference in post-operative pain for TKA patients without femoral nerve block receiving an intra-operative pericapsular injection of bupivacaine liposome suspension (EXPAREL; Pacira Pharmaceuticals, Inc., San Diego, California) versus a concentrated multi drug cocktail. Seventy TKA patients were randomly assigned to either the bupivacaine liposome or the multi-drug cocktail. Post-operative pain scores, morphine sulfate equivalence consumption values, adverse events, and overall pain control satisfaction scores were collected. Patients reported significantly higher pain level for the cocktail group on post-op day 1 (p < .05) and post-op day 2 (p < .01) versus the bupivacaine liposome group. This same trend was found for morphine sulfate equivalence consumption in the PACU (p < .01) and post-op day 2 (p < .01). Higher satisfaction in pain control (p < .001) and overall experience (p < .01) was also found in the bupivacaine liposome group. Finally, significantly more adverse events were found in the multi-drug group versus the bupivacaine liposome group (p < .05). The study findings demonstrated a non-inferior difference, albeit not a clinically significant difference, in patient-perceived pain scores, morphine sulfate equivalence consumption, adverse events, and overall satisfaction.
first_indexed 2024-12-19T04:03:10Z
format Article
id doaj.art-0fb1967e22f34b9491fd6ca982f30731
institution Directory Open Access Journal
issn 2352-3441
language English
last_indexed 2024-12-19T04:03:10Z
publishDate 2016-03-01
publisher Elsevier
record_format Article
series Arthroplasty Today
spelling doaj.art-0fb1967e22f34b9491fd6ca982f307312022-12-21T20:36:38ZengElsevierArthroplasty Today2352-34412016-03-0121374210.1016/j.artd.2015.05.005Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspensionMark A. Snyder, MD0Christina M. Scheuerman, BSN, RN1Justin L. Gregg, MA2Christopher J. Ruhnke, MD3Kathryn Eten, BSN, RN4Orthopaedic Center of Excellence, TriHealth Orthopaedic and Spine Institute, Cincinnati, OH, USATriHealth Hatton Research Institute, Cincinnati, OH, USATriHealth Hatton Research Institute, Cincinnati, OH, USATriHealth Orthopaedic and Spine Institute, Cincinnati, OH, USAOrthopaedic Center of Excellence, Good Samaritan Hospital, Cincinnati, OH, USAPatients undergoing total knee arthroplasty (TKA) report low satisfaction with postoperative pain control. The purpose of this study is to examine if there is a difference in post-operative pain for TKA patients without femoral nerve block receiving an intra-operative pericapsular injection of bupivacaine liposome suspension (EXPAREL; Pacira Pharmaceuticals, Inc., San Diego, California) versus a concentrated multi drug cocktail. Seventy TKA patients were randomly assigned to either the bupivacaine liposome or the multi-drug cocktail. Post-operative pain scores, morphine sulfate equivalence consumption values, adverse events, and overall pain control satisfaction scores were collected. Patients reported significantly higher pain level for the cocktail group on post-op day 1 (p < .05) and post-op day 2 (p < .01) versus the bupivacaine liposome group. This same trend was found for morphine sulfate equivalence consumption in the PACU (p < .01) and post-op day 2 (p < .01). Higher satisfaction in pain control (p < .001) and overall experience (p < .01) was also found in the bupivacaine liposome group. Finally, significantly more adverse events were found in the multi-drug group versus the bupivacaine liposome group (p < .05). The study findings demonstrated a non-inferior difference, albeit not a clinically significant difference, in patient-perceived pain scores, morphine sulfate equivalence consumption, adverse events, and overall satisfaction.http://www.sciencedirect.com/science/article/pii/S2352344115000345Total knee arthroplastyPainPericapsular injection
spellingShingle Mark A. Snyder, MD
Christina M. Scheuerman, BSN, RN
Justin L. Gregg, MA
Christopher J. Ruhnke, MD
Kathryn Eten, BSN, RN
Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
Arthroplasty Today
Total knee arthroplasty
Pain
Pericapsular injection
title Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
title_full Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
title_fullStr Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
title_full_unstemmed Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
title_short Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
title_sort improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension
topic Total knee arthroplasty
Pain
Pericapsular injection
url http://www.sciencedirect.com/science/article/pii/S2352344115000345
work_keys_str_mv AT markasnydermd improvingtotalkneearthroplastyperioperativepainmanagementusingaperiarticularinjectionwithbupivacaineliposomalsuspension
AT christinamscheuermanbsnrn improvingtotalkneearthroplastyperioperativepainmanagementusingaperiarticularinjectionwithbupivacaineliposomalsuspension
AT justinlgreggma improvingtotalkneearthroplastyperioperativepainmanagementusingaperiarticularinjectionwithbupivacaineliposomalsuspension
AT christopherjruhnkemd improvingtotalkneearthroplastyperioperativepainmanagementusingaperiarticularinjectionwithbupivacaineliposomalsuspension
AT kathrynetenbsnrn improvingtotalkneearthroplastyperioperativepainmanagementusingaperiarticularinjectionwithbupivacaineliposomalsuspension